Early research (Phase 1)Study completedNCT00003548What this trial is testingAminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal CavityWho this might be right forCancer NYU Langone Health 20
Early research (Phase 1)Active Not RecruitingNCT02567422What this trial is testingTesting the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck CancerWho this might be right forHead and Neck Carcinoma of Unknown PrimaryHead and Neck Squamous Cell CarcinomaStage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7+9 more National Cancer Institute (NCI) 43
Large-scale testing (Phase 3)Study completedNCT03258554What this trial is testingRadiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take CisplatinWho this might be right forClinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Head and Neck Squamous Cell CarcinomaHypopharyngeal Squamous Cell Carcinoma+17 more National Cancer Institute (NCI) 196
Early research (Phase 1)Looking for participantsNCT05172245What this trial is testingTesting the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck CancerWho this might be right forClinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Head and Neck Carcinoma of Unknown Primary+24 more National Cancer Institute (NCI)
Not applicableWithdrawnNCT00499291What this trial is testingPaclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid TumorsWho this might be right forCancer Eastern Cooperative Oncology Group
Not applicableLooking for participantsNCT03010150What this trial is testingBlood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck CancerWho this might be right forCarcinoma of Unknown PrimaryClinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+28 more M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06995508What this trial is testingOlanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO TrialWho this might be right forCancer-Associated AnorexiaHead and Neck Squamous Cell CarcinomaNeck Squamous Cell Carcinoma of Unknown Primary Roswell Park Cancer Institute 66
Testing effectiveness (Phase 2)Study completedNCT00003657What this trial is testingHigh-dose ICE With AmifostineWho this might be right forBladder CancerBrain and Central Nervous System TumorsCarcinoma of Unknown Primary+8 more Dana-Farber Cancer Institute 24
Not applicableLooking for participantsNCT07283939What this trial is testingStudying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment DelaysWho this might be right forAmpulla of Vater CarcinomaAppendix CarcinomaCarcinoma of Unknown Primary With Gastrointestinal Profile+7 more Alliance for Clinical Trials in Oncology 420
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15
Not applicableStudy completedNCT00656760What this trial is testingPET/CT: Role in Detecting Unknown Primary Head and Neck CancerWho this might be right forHead and Neck Cancer University of Calgary 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06578871What this trial is testingSurgery and Reducing Ionizing Radiation of the Unknown PrimaryWho this might be right forHead and Neck Squamous Cell CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 90
Not applicableWithdrawnNCT04985357What this trial is testingDefining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsWho this might be right forStage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more Travera Inc
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75